Aethlon Medical, a developmental-stage medical device company, has completed a human safety study conducted at the Fortis Hospital in Delhi, India.

Aethlon Medical, Inc. (OTCBB:AEMD) today announced the completion of a human safety study conducted at the Fortis Hospital in Delhi, India.

Aethlon Medical, Inc. (OTCBB:AEMD) today announced preliminary data of Hepatitis-C (HCV) infected patients treated with the Aethlon Hemopurifier(R), a medical device designed to assist the immune response in combating infectious disease.

Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing medical devices to treat infectious disease, disclosed its Chairman and CEO, James A.

Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing medical devices to treat infectious disease, announced today that it has initiated clinical testing the Aethlon Hemopurifier® in human studies being conducted at the Fortis Hospital in Delhi, India.